Inventor

THIBERT ROCH

CA14 patents

⚠️ This page may combine multiple inventors who share the name “THIBERT ROCH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KARUNA THERAPEUTICS INC

6 patents

US10933020B2Mar 2, 2021

Compositions and methods for treating disorders ameliorated by muscarinic receptor activation

KARUNA THERAPEUTICS INC5 citations82

US10925832B2Feb 23, 2021

Compositions and methods for treatment of disorders ameliorated by muscarinic receptor activation

KARUNA THERAPEUTICS INC5 citations82

US11890378B2Feb 6, 2024

Compositions and methods for treating disorders ameliorated by muscarinic receptor activation

KARUNA THERAPEUTICS INC1 citations71

US11471413B2Oct 18, 2022

Compositions and methods for treating disorders ameliorated by muscarinic receptor activation

KARUNA THERAPEUTICS INC2 citations71

US11452692B2Sep 27, 2022

Compositions and methods for treating disorders ameliorated by muscarinic receptor activation

KARUNA THERAPEUTICS INC2 citations71

US12558317B2Feb 24, 2026

Compositions and methods for treating disorders ameliorated by muscarinic receptor activation

KARUNA THERAPEUTICS INC0 citations61

LAURENT PHARMACEUTICALS

2 patents

US10512619B2Dec 24, 2019

Solid oral formulation of fenretinide

LAURENT PHARMACEUTICALS3 citations69

US10406127B2Sep 10, 2019

Solid oral formulation of fenretinide

LAURENT PHARMACEUTICALS3 citations69

BETANCOURT AIMESTHER

1 patent

US8703956B2Apr 22, 2014

Amorphous (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid

BETANCOURT AIMESTHER6 citations78

ATOPIX THERAPEUTICS LTD

1 patent

US8980918B2Mar 17, 2015

Amorphous (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid

ATOPIX THERAPEUTICS LTD3 citations60

MERCK & CO INC

1 patent

US6740666B2May 25, 2004

Substituted 8-arylquinoline phosphodiesterase-4 inhibitors

MERCK & CO INC5 citations58

UNIV MICHIGAN REGENTS

1 patent

US12151998B2Nov 26, 2024

Solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N′-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride and compositions, methods and kits related thereto

UNIV MICHIGAN REGENTS0 citations56

ATTEROCOR INC

1 patent

US9546135B2Jan 17, 2017

Solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N′-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride and compositions, methods and kits related thereto

ATTEROCOR INC1 citations51

MILLENDO THERAPEUTICS INC

1 patent

US10059660B2Aug 28, 2018

Solid drug form of N-(2,6-bis(1-methylethyl)phenyl)-N′-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride and compositions, methods and kits related thereto

MILLENDO THERAPEUTICS INC0 citations43